[A drug for therapy of obesity: really only life style? (interview by Dirk Einecke)].
Wirth
Alfred
A
D001067:Appetite Depressants / Q000627:therapeutic use*; D063387:Cannabinoid Receptor Antagonists; D017277:Drug Approval; D005858:Germany; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008019:Life Style; D024821:Metabolic Syndrome / Q000188:drug therapy*; D009313:National Health Programs; D009765:Obesity / Q000188:drug therapy*; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011788:Quality of Life; D000077285:Rimonabant
D001067:Appetite Depressants; D063387:Cannabinoid Receptor Antagonists; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant